1.1M XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 15 Mar 2025 | 1,242 | 476,268 (1%) | 0% | 7.1 | 8,769 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 15 Mar 2025 | 229 | 84,195 (0%) | 0% | 7.1 | 1,617 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.59 per share. | 28 Feb 2025 | 247 | 477,510 (1%) | 0% | 7.6 | 1,875 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 15 Feb 2025 | 752 | 477,757 (1%) | 0% | 8.1 | 6,054 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 15 Feb 2025 | 92 | 84,424 (0%) | 0% | 8.1 | 741 | Common Stock |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 454,641 | 454,641 | - | - | Stock Option (right to buy) | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 138,790 | 478,509 (1%) | 0% | 0 | Common Stock | |
| Vandana Sriram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 50,712 | 84,516 (0%) | 0% | 0 | Common Stock | |
| Vandana Sriram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 166,119 | 166,119 | - | - | Stock Option (right to buy) | |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 02 Feb 2025 | 2,166 | 33,804 (0%) | 0% | 9.2 | 19,906 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 31 Jan 2025 | 6,077 | 339,719 (1%) | 0% | 9.2 | 55,848 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 31 Jan 2025 | 298 | 345,796 (1%) | 0% | 9.2 | 2,739 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.62 per share. | 15 Jan 2025 | 906 | 346,094 (1%) | 0% | 8.6 | 7,810 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.62 per share. | 15 Jan 2025 | 93 | 35,970 (0%) | 0% | 8.6 | 802 | Common Stock |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 1,494,777 (5%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 53,436 (0%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Options (Right to buy) | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 10.76 per share. | 02 Jan 2025 | 1,394 | 54,830 (0%) | 0% | 10.8 | 14,999 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 36,908 (0%) | 0% | 0 | Common Stock | |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 42,018 (0%) | 0% | 0 | Common Stock | |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 10.76 per share. | 02 Jan 2025 | 1,282 | 43,300 (0%) | 0% | 10.8 | 13,794 | Common Stock |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Options (Right to buy) | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 10.76 per share. | 02 Jan 2025 | 1,394 | 304,558 (1%) | 0% | 10.8 | 14,999 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Options (Right to buy) | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 303,164 (1%) | 0% | 0 | Common Stock | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 33,840 (0%) | 0% | 0 | Common Stock | |
| Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 19,420 (0%) | 0% | 0 | Common Stock | |
| Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.63 per share. | 31 Dec 2024 | 415 | 347,000 (1%) | 0% | 10.6 | 4,411 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.68 per share. | 15 Dec 2024 | 752 | 347,415 (1%) | 0% | 10.7 | 8,031 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.68 per share. | 15 Dec 2024 | 75 | 36,063 (0%) | 0% | 10.7 | 801 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.33 per share. | 30 Nov 2024 | 368 | 348,167 (1%) | 0% | 12.3 | 4,537 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.44 per share. | 15 Nov 2024 | 1,120 | 348,535 (1%) | 0% | 11.4 | 12,813 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.44 per share. | 15 Nov 2024 | 78 | 36,138 (0%) | 0% | 11.4 | 892 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.22 per share. | 31 Oct 2024 | 368 | 349,655 (1%) | 0% | 13.2 | 4,865 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.48 per share. | 15 Oct 2024 | 1,120 | 350,023 (1%) | 0% | 12.5 | 13,978 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.47 per share. | 15 Oct 2024 | 78 | 36,216 (0%) | 0% | 12.5 | 973 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 01 Oct 2024 | 1,200 | 46,001 (0%) | 0% | 12.5 | 15,000 | Common Stock |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 01 Oct 2024 | 1,000 | 34,583 (0%) | 0% | 12.5 | 12,500 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 12.50 per share. | 01 Oct 2024 | 1,200 | 295,729 (1%) | 0% | 12.5 | 15,000 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.50 per share. | 30 Sep 2024 | 368 | 351,143 (1%) | 0% | 12.5 | 4,600 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. | 15 Sep 2024 | 1,120 | 351,511 (1%) | 0% | 12.8 | 14,358 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. | 15 Sep 2024 | 78 | 36,294 (0%) | 0% | 12.8 | 1,000 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.03 per share. | 31 Aug 2024 | 368 | 352,631 (1%) | 0% | 13.0 | 4,795 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.15 per share. | 21 Aug 2024 | 927 | 36,372 (0%) | 0% | 13.1 | 12,190 | Common Stock |
| David R. Walt | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Aug 2024 | 1,000 | 1,440,342 (5%) | 0% | 0 | Common Stock | |
| David R. Walt | Director | Purchase of securities on an exchange or from another person at price $ 13.29 per share. | 20 Aug 2024 | 47,000 | 1,487,342 (5%) | 0% | 13.3 | 624,630 | Common Stock |
| David R. Walt | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Aug 2024 | 1,000 | 1,441,342 (5%) | 0% | 0 | Common Stock | |
| Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 25,908 | 25,908 | - | - | Stock Option (right to buy) | |
| Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 11,985 | 11,985 (0%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.35 per share. | 15 Aug 2024 | 1,120 | 352,999 (1%) | 0% | 11.4 | 12,712 | Common Stock |
| Masoud Toloue | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 13 Aug 2024 | 19,000 | 354,119 (1%) | 0% | 10.9 | 207,100 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.76 per share. | 31 Jul 2024 | 368 | 335,119 (1%) | 0% | 14.8 | 5,432 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 15 Jul 2024 | 1,120 | 335,487 (1%) | 0% | 15.1 | 16,890 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 12.68 per share. | 01 Jul 2024 | 1,182 | 44,801 (0%) | 0% | 12.7 | 14,988 | Common Stock |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 12.68 per share. | 01 Jul 2024 | 985 | 33,583 (0%) | 0% | 12.7 | 12,490 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 12.68 per share. | 01 Jul 2024 | 1,182 | 294,529 (1%) | 0% | 12.7 | 14,988 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.21 per share. | 30 Jun 2024 | 368 | 336,607 (1%) | 0% | 13.2 | 4,861 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.32 per share. | 15 Jun 2024 | 1,120 | 336,975 (1%) | 0% | 13.3 | 14,918 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.97 per share. | 31 May 2024 | 1,054 | 338,095 (1%) | 0% | 16.0 | 16,832 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 15 May 2024 | 1,120 | 339,149 (1%) | 0% | 17.9 | 20,026 | Common Stock |
| Laurie J. Olson | Director | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 14 May 2024 | 1,500 | 13,738 (0%) | 0% | 17.0 | 25,470 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.12 per share. | 30 Apr 2024 | 1,049 | 340,269 (1%) | 0% | 16.1 | 16,910 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.15 per share. | 15 Apr 2024 | 1,120 | 341,318 (1%) | 0% | 17.2 | 19,208 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 23.78 per share. | 01 Apr 2024 | 630 | 43,619 (0%) | 0% | 23.8 | 14,981 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 23.78 per share. | 01 Apr 2024 | 630 | 293,347 (1%) | 0% | 23.8 | 14,981 | Common Stock |
| Laurie J. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 1,000 | 10,124 | - | - | Stock Option (Right to Buy) | |
| Laurie J. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.86 per share. | 01 Apr 2024 | 1,000 | 16,238 (0%) | 0% | 12.9 | 12,860 | Common Stock |
| Laurie J. Olson | Director | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 01 Apr 2024 | 1,000 | 15,238 (0%) | 0% | 23.5 | 23,500 | Common Stock |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 23.78 per share. | 01 Apr 2024 | 525 | 32,598 (0%) | 0% | 23.8 | 12,485 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.56 per share. | 31 Mar 2024 | 1,120 | 342,438 (1%) | 0% | 23.6 | 26,387 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.55 per share. | 15 Mar 2024 | 1,120 | 343,558 (1%) | 0% | 26.6 | 29,736 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.96 per share. | 29 Feb 2024 | 724 | 344,678 (1%) | 0% | 24.0 | 17,347 | Common Stock |
| J. Olson Laurie | Director | Sale of securities on an exchange or to another person at price $ 24.35 per share. | 14 Feb 2024 | 1,500 | 15,238 (0%) | 0% | 24.4 | 36,525 | Common Stock |
| Sriram Vandana | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 83,038 | 83,038 | - | - | Stock Option (right to buy) | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 67,532 | 353,799 (1%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 227,262 | 227,262 | - | - | Stock Option (right to buy) | |
| Sriram Vandana | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 24,675 | 37,299 (0%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.10 per share. | 02 Feb 2024 | 8,397 | 345,402 (1%) | 0% | 23.1 | 193,971 | Common Stock |
| Toloue Masoud | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.09 per share. | 31 Jan 2024 | 763 | 286,267 (1%) | 0% | 22.1 | 16,855 | Common Stock |
| Laurie J. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.86 per share. | 02 Jan 2024 | 1,000 | 17,738 (0%) | 0% | 12.9 | 12,860 | Common Stock |
| M. Paul Meister | Director | Grant, award, or other acquisition of securities at price $ 27.15 per share. | 02 Jan 2024 | 552 | 292,717 (1%) | 0% | 27.2 | 14,987 | Common Stock |
| M. Meister Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Laurie J. Olson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 1,000 | 11,124 | - | - | Stock Option (Right to Buy) | |
| E. Hlavinka Sarah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 42,437 (0%) | 0% | 0 | Common Stock | |
| Karen Flynn A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 26,405 (0%) | 0% | 0 | Common Stock | |
| Hlavinka E. Sarah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Olson Laurie J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Olson J. Laurie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 16,738 (0%) | 0% | 0 | Common Stock | |
| Brian Blaser J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 19,049 (0%) | 0% | 0 | Common Stock | |
| D. Martin Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 29,473 (0%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 27.15 per share. | 02 Jan 2024 | 552 | 42,989 (0%) | 0% | 27.2 | 14,987 | Common Stock |
| Flynn Karen A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 31,613 (0%) | 0% | 0 | Common Stock | |
| William P. Donnelly | Director | Grant, award, or other acquisition of securities at price $ 27.15 per share. | 02 Jan 2024 | 460 | 32,073 (0%) | 0% | 27.2 | 12,489 | Common Stock |
| Donnelly P. William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Walt R. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Laurie J. Olson | Director | Sale of securities on an exchange or to another person at price $ 26.91 per share. | 02 Jan 2024 | 1,000 | 16,738 (0%) | 0% | 26.9 | 26,910 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | |
| Meister Paul M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 292,165 (1%) | 0% | 0 | Common Stock | |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 1,442,342 (5%) | 0% | 0 | Common Stock | |
| Toloue Masoud | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.34 per share. | 31 Dec 2023 | 859 | 287,030 (1%) | 0% | 27.3 | 23,485 | Common Stock |
| Vandana Sriram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 29,455 | 29,455 | - | - | Stock Option (right to buy) | |
| Vandana Sriram | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 12,624 | 12,624 (0%) | 0% | 0 | Common Stock | |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.84 per share. | 31 Jul 2023 | 117 | 88,566 (0%) | 0% | 24.8 | 2,906 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.84 per share. | 31 Jul 2023 | 638 | 290,441 (1%) | 0% | 24.8 | 15,848 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 21.82 per share. | 03 Jul 2023 | 687 | 38,929 (0%) | 0% | 21.8 | 14,990 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 21.82 per share. | 03 Jul 2023 | 687 | 288,657 (1%) | 0% | 21.8 | 14,990 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.55 per share. | 30 Jun 2023 | 117 | 88,683 (0%) | 0% | 22.5 | 2,638 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.55 per share. | 30 Jun 2023 | 638 | 291,079 (1%) | 0% | 22.6 | 14,387 | Common Stock |
| Paul M. Meister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 23,335 | 0 | - | - | Stock Options (Right to buy) | |
| Paul M. Meister | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.89 per share. | 07 Jun 2023 | 23,335 | 287,970 (1%) | 0% | 2.9 | 67,438 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. | 31 May 2023 | 117 | 88,800 (0%) | 0% | 19.6 | 2,294 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. | 31 May 2023 | 638 | 291,717 (1%) | 0% | 19.6 | 12,511 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.64 per share. | 25 Apr 2023 | 638 | 292,355 (1%) | 0% | 12.6 | 8,064 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.67 per share. | 25 Apr 2023 | 2,683 | 292,993 (1%) | 0% | 11.7 | 31,311 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.63 per share. | 07 Apr 2023 | 1,006 | 89,036 (0%) | 0% | 12.6 | 12,706 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.64 per share. | 07 Apr 2023 | 119 | 88,917 (0%) | 0% | 12.6 | 1,504 | Common Stock |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 11.16 per share. | 03 Apr 2023 | 1,170 | 131,236 (0%) | 0% | 11.2 | 13,057 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 11.16 per share. | 03 Apr 2023 | 1,344 | 38,242 (0%) | 0% | 11.2 | 14,999 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 11.16 per share. | 03 Apr 2023 | 1,344 | 264,635 (0%) | 0% | 11.2 | 14,999 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 31 Mar 2023 | 35 | 90,042 (0%) | 0% | 11.3 | 394 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.27 per share. | 31 Mar 2023 | 414 | 295,676 (1%) | 0% | 11.3 | 4,666 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.00 per share. | 28 Feb 2023 | 41 | 90,077 (0%) | 0% | 11 | 451 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.00 per share. | 28 Feb 2023 | 418 | 296,090 (1%) | 0% | 11 | 4,598 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 41,692 | 90,118 (0%) | 0% | 0 | Common Stock | |
| Michael A. Doyle | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 97,281 | 97,281 | - | - | Stock Option (right to buy) | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 111,178 | 296,508 (1%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 259,416 | 259,416 | - | - | Stock Option (right to buy) | |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.12 per share. | 31 Jan 2023 | 41 | 48,426 (0%) | 0% | 14.1 | 579 | Common Stock |
| Masoud Toloue | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 31 Jan 2023 | 493 | 185,330 (0%) | 0% | 14.1 | 6,966 | Common Stock |
| Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 24,153 | 24,153 | - | - | Stock Option (right to buy) | |
| Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 16,102 | 16,102 (0%) | 0% | 0 | Common Stock | |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 1,439,395 (5%) | 0% | 0 | Common Stock | |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 129,051 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 1,015 | 130,066 (0%) | 0% | 12.9 | 13,053 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 35,732 (0%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 1,166 | 36,898 (0%) | 0% | 12.9 | 14,995 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 26,526 (0%) | 0% | 0 | Common Stock | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 1,166 | 263,291 (0%) | 0% | 12.9 | 14,995 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 262,125 (0%) | 0% | 0 | Common Stock | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 22,540 (0%) | 0% | 0 | Common Stock | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 12.86 per share. | 03 Jan 2023 | 918 | 23,458 (0%) | 0% | 12.9 | 11,805 | Common Stock |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 12,124 | 12,124 | - | - | Stock Option (Right to Buy) | |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 8,083 | 15,291 (0%) | 0% | 0 | Common Stock | |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 31 Dec 2022 | 42 | 48,467 (0%) | 0% | 13.9 | 582 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 30 Nov 2022 | 35 | 48,509 (0%) | 0% | 13.3 | 466 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 03 Nov 2022 | 35 | 48,544 (0%) | 0% | 11.1 | 387 | Common Stock |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,326 | 120,968 (0%) | 0% | 10.5 | 13,896 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,379 | 27,649 (0%) | 0% | 10.5 | 14,452 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,431 | 254,042 (0%) | 0% | 10.5 | 14,997 | Common Stock |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 10.48 per share. | 03 Oct 2022 | 1,066 | 14,457 (0%) | 0% | 10.5 | 11,172 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 30 Sep 2022 | 35 | 48,579 (0%) | 0% | 11.0 | 386 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 10.43 per share. | 12 Aug 2022 | 15,000 | 33,614 (0%) | 0% | 10.4 | 156,503 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 10.16 per share. | 12 Aug 2022 | 15,000 | 48,614 (0%) | 0% | 10.2 | 152,418 | Common Stock |
| Masoud Toloue | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 10.43 per share. | 12 Aug 2022 | 105,000 | 185,823 (0%) | 0% | 10.4 | 1,095,150 | Common Stock |
| Sarah E. Hlavinka | Director | Purchase of securities on an exchange or from another person at price $ 10.46 per share. | 11 Aug 2022 | 4,760 | 26,270 (0%) | 0% | 10.5 | 49,788 | Common Stock |
| Sarah E. Hlavinka | Director | Purchase of securities on an exchange or from another person at price $ 9.38 per share. | 11 Aug 2022 | 5,400 | 21,510 (0%) | 0% | 9.4 | 50,652 | Common Stock |
| David R. Walt | Director | Purchase of securities on an exchange or from another person at price $ 8.62 per share. | 10 Aug 2022 | 150,000 | 1,431,312 (5%) | 0% | 8.6 | 1,293,495 | Common Stock |
| Martin D. Madaus | Director | Purchase of securities on an exchange or from another person at price $ 8.43 per share. | 10 Aug 2022 | 89,667 | 254,633 (0%) | 0% | 8.4 | 755,543 | Common Stock |
| Paul M. Meister | Director | Purchase of securities on an exchange or from another person at price $ 8.61 per share. | 10 Aug 2022 | 47,957 | 252,611 (0%) | 0% | 8.6 | 412,780 | Common Stock |
| Paul M. Meister | Director | Purchase of securities on an exchange or from another person at price $ 8.51 per share. | 10 Aug 2022 | 186,347 | 204,654 (0%) | 0% | 8.5 | 1,585,533 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 01 Aug 2022 | 401 | 37,671 (0%) | 0% | 15.6 | 6,261 | Common Stock |
| Masoud Toloue | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 01 Aug 2022 | 446 | 80,823 (0%) | 0% | 15.6 | 6,964 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 15.62 per share. | 13 Jul 2022 | 37 | 18,614 (0%) | 0% | 15.6 | 578 | Common Stock |
| Michael A. Doyle | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 13 Jul 2022 | 434 | 18,651 (0%) | 0% | 18.2 | 7,879 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 16.57 per share. | 05 Jul 2022 | 387 | 38,072 (0%) | 0% | 16.6 | 6,412 | Common Stock |
| E. Kevin Hrusovsky | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 16.57 per share. | 05 Jul 2022 | 960 | 910,249 (3%) | 0% | 16.6 | 15,906 | Common Stock |
| Masoud Toloue | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.57 per share. | 05 Jul 2022 | 432 | 81,269 (0%) | 0% | 16.6 | 7,158 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 893 | 119,642 (0%) | 0% | 16.8 | 14,993 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 819 | 16,110 (0%) | 0% | 16.8 | 13,751 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 893 | 18,307 (0%) | 0% | 16.8 | 14,993 | Common Stock |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 01 Jul 2022 | 164 | 13,391 (0%) | 0% | 16.8 | 2,754 | Common Stock |
| Masoud Toloue | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 15.27 per share. | 13 Jun 2022 | 5,564 | 81,701 (0%) | 0% | 15.3 | 84,955 | Common Stock |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 19,841 | 19,841 | - | - | Stock Option (right to buy) | |
| Karen A. Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 13,227 | 13,227 (0%) | 0% | 0 | Common Stock | |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 17.47 per share. | 02 Jun 2022 | 378 | 38,459 (0%) | 0% | 17.5 | 6,605 | Common Stock |
| E. Kevin Hrusovsky | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 17.47 per share. | 02 Jun 2022 | 712 | 911,209 (3%) | 0% | 17.5 | 12,441 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 22.68 per share. | 02 May 2022 | 84 | 38,837 (0%) | 0% | 22.7 | 1,905 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 02 May 2022 | 345 | 38,921 (0%) | 0% | 22.3 | 7,689 | Common Stock |
| E. Kevin Hrusovsky | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 02 May 2022 | 522 | 912,048 (3%) | 0% | 22.3 | 11,634 | Common Stock |
| E. Kevin Hrusovsky | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 22.69 per share. | 02 May 2022 | 127 | 911,921 (3%) | 0% | 22.7 | 2,881 | Common Stock |
| E. Kevin Hrusovsky | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 59,718 | 59,718 | - | - | Stock Options (Right to buy) | |
| E. Kevin Hrusovsky | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 25,594 | 912,570 (3%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 36,562 | 87,265 (0%) | 0% | 0 | Common Stock | |
| Masoud Toloue | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 85,312 | 85,312 | - | - | Stock Options (Right to buy) | |
| John J. Fry | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 21,086 | 21,086 | - | - | Stock Option (right to buy) | |
| Michael A. Doyle | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 31,629 | 31,629 | - | - | Stock Option (right to buy) | |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 29.79 per share. | 01 Apr 2022 | 524 | 30,229 (0%) | 0% | 29.8 | 15,611 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 01 Apr 2022 | 492 | 118,749 (0%) | 0% | 30.5 | 14,991 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 01 Apr 2022 | 451 | 15,291 (0%) | 0% | 30.5 | 13,742 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 29.79 per share. | 01 Apr 2022 | 868 | 886,976 (3%) | 0% | 29.8 | 25,860 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 01 Apr 2022 | 492 | 17,414 (0%) | 0% | 30.5 | 14,991 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 29.80 per share. | 01 Apr 2022 | 171 | 22,325 (0%) | 0% | 29.8 | 5,095 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 29.79 per share. | 01 Apr 2022 | 261 | 36,876 (0%) | 0% | 29.8 | 7,776 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 23 Mar 2022 | 3,266 | 54,730 (0%) | 0% | 30 | 97,980 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 01 Mar 2022 | 272 | 30,852 (0%) | 0% | 31.2 | 8,488 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 01 Mar 2022 | 99 | 30,753 (0%) | 0% | 32.2 | 3,183 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 01 Mar 2022 | 158 | 887,844 (3%) | 0% | 32.2 | 5,080 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 01 Mar 2022 | 431 | 888,002 (3%) | 0% | 31.2 | 13,450 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 31.20 per share. | 01 Mar 2022 | 122 | 22,540 (0%) | 0% | 31.2 | 3,807 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 32.16 per share. | 01 Mar 2022 | 44 | 22,496 (0%) | 0% | 32.2 | 1,415 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 31.20 per share. | 01 Mar 2022 | 196 | 37,208 (0%) | 0% | 31.2 | 6,116 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 01 Mar 2022 | 71 | 37,137 (0%) | 0% | 32.2 | 2,283 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Feb 2022 | 481 | 31,124 (0%) | 0% | 35.0 | 16,820 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Feb 2022 | 1,364 | 888,433 (3%) | 0% | 35.0 | 47,697 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Feb 2022 | 292 | 22,662 (0%) | 0% | 35.0 | 10,211 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Feb 2022 | 318 | 37,404 (0%) | 0% | 35.0 | 11,120 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 30.91 per share. | 04 Feb 2022 | 3,266 | 57,996 (0%) | 0% | 30.9 | 100,952 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 02 Feb 2022 | 99 | 31,605 (0%) | 0% | 32.2 | 3,183 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 02 Feb 2022 | 272 | 31,704 (0%) | 0% | 31.2 | 8,488 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 02 Feb 2022 | 158 | 889,797 (3%) | 0% | 32.2 | 5,080 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 02 Feb 2022 | 431 | 889,955 (3%) | 0% | 31.2 | 13,450 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 31.20 per share. | 02 Feb 2022 | 122 | 22,998 (0%) | 0% | 31.2 | 3,807 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 32.16 per share. | 02 Feb 2022 | 44 | 22,954 (0%) | 0% | 32.2 | 1,415 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 31.20 per share. | 02 Feb 2022 | 196 | 37,793 (0%) | 0% | 31.2 | 6,116 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 32.15 per share. | 02 Feb 2022 | 71 | 37,722 (0%) | 0% | 32.2 | 2,283 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 31 Jan 2022 | 3,266 | 61,262 (0%) | 0% | 30 | 97,980 | Common Stock |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| David R. Walt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 1,281,312 (4%) | 0% | 0 | Common Stock | |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 41.91 per share. | 03 Jan 2022 | 352 | 31,976 (0%) | 0% | 41.9 | 14,751 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 03 Jan 2022 | 307 | 118,257 (0%) | 0% | 42.4 | 13,020 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 117,950 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 9,318 | 115,282 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 189,311 | 177,247 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 177,247 | 0 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 9,952 | 105,964 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 120,689 | 113,003 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jan 2022 | 113,003 | 0 (0%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 03 Jan 2022 | 280 | 14,840 (0%) | 0% | 42.4 | 11,875 | Common Stock |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 14,560 (0%) | 0% | 0 | Common Stock | |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 41.91 per share. | 03 Jan 2022 | 3,715 | 890,386 (3%) | 0% | 41.9 | 155,683 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 03 Jan 2022 | 427 | 18,443 (0%) | 0% | 42.4 | 18,109 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 18,016 (0%) | 0% | 0 | Common Stock | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 03 Jan 2022 | 324 | 16,922 (0%) | 0% | 42.4 | 13,741 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 16,598 (0%) | 0% | 0 | Common Stock | |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 41.91 per share. | 03 Jan 2022 | 149 | 23,120 (0%) | 0% | 41.9 | 6,244 | Common Stock |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,002 | 4,002 | - | - | Stock Option (Right to Buy) | |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,668 | 7,208 (0%) | 0% | 0 | Common Stock | |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 4,667 | 0 | - | - | Stock Option (right to buy) | |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.89 per share. | 03 Jan 2022 | 15,556 | 43,505 (0%) | 0% | 2.9 | 44,957 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.28 per share. | 03 Jan 2022 | 21,023 | 64,528 (0%) | 0% | 2.3 | 47,932 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.96 per share. | 03 Jan 2022 | 4,667 | 27,949 (0%) | 0% | 3.0 | 13,814 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 15,556 | 0 | - | - | Stock Option (right to buy) | |
| David C. Duffy | SVP R&D and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 21,023 | 0 | - | - | Stock Option (Right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 41.91 per share. | 03 Jan 2022 | 355 | 37,989 (0%) | 0% | 41.9 | 14,877 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 40.71 per share. | 29 Dec 2021 | 1,667 | 23,282 (0%) | 0% | 40.7 | 67,864 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 40.26 per share. | 01 Dec 2021 | 338 | 32,340 (0%) | 0% | 40.3 | 13,609 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 01 Dec 2021 | 12 | 32,328 (0%) | 0% | 41 | 492 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 01 Dec 2021 | 131 | 894,101 (3%) | 0% | 41 | 5,371 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 40.26 per share. | 01 Dec 2021 | 3,579 | 894,232 (3%) | 0% | 40.3 | 144,106 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 40.27 per share. | 01 Dec 2021 | 142 | 23,274 (0%) | 0% | 40.3 | 5,718 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 01 Dec 2021 | 5 | 23,269 (0%) | 0% | 41 | 205 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 40.26 per share. | 01 Dec 2021 | 341 | 38,356 (0%) | 0% | 40.3 | 13,730 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 01 Dec 2021 | 12 | 38,344 (0%) | 0% | 41 | 492 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 45.54 per share. | 19 Nov 2021 | 1,667 | 24,949 (0%) | 0% | 45.5 | 75,915 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 55.37 per share. | 10 Nov 2021 | 3,700 | 898,211 (3%) | 0% | 55.4 | 204,862 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 10 Nov 2021 | 400 | 897,811 (3%) | 0% | 56.0 | 22,387 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 54.05 per share. | 10 Nov 2021 | 900 | 901,911 (3%) | 0% | 54.1 | 48,649 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 04 Nov 2021 | 10,718 | 47,232 (0%) | 0% | 19.1 | 204,928 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 10,718 | 10,557 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 58.40 per share. | 04 Nov 2021 | 200 | 38,697 (0%) | 0% | 58.4 | 11,679 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 57.25 per share. | 04 Nov 2021 | 8,335 | 38,897 (0%) | 0% | 57.2 | 477,173 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 04 Nov 2021 | 1 | 36,514 (0%) | 0% | 57 | 57 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 53.14 per share. | 02 Nov 2021 | 92 | 32,678 (0%) | 0% | 53.1 | 4,889 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 52.40 per share. | 02 Nov 2021 | 239 | 32,770 (0%) | 0% | 52.4 | 12,523 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 53.15 per share. | 02 Nov 2021 | 979 | 902,811 (3%) | 0% | 53.1 | 52,029 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 52.40 per share. | 02 Nov 2021 | 2,526 | 903,790 (3%) | 0% | 52.4 | 132,356 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 52.40 per share. | 02 Nov 2021 | 100 | 23,455 (0%) | 0% | 52.4 | 5,240 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 53.15 per share. | 02 Nov 2021 | 39 | 23,416 (0%) | 0% | 53.2 | 2,073 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 53.14 per share. | 02 Nov 2021 | 93 | 36,515 (0%) | 0% | 53.1 | 4,942 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 52.40 per share. | 02 Nov 2021 | 240 | 36,608 (0%) | 0% | 52.4 | 12,575 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 22 Oct 2021 | 3,000 | 906,416 (3%) | 0% | 51.0 | 152,998 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.63 per share. | 22 Oct 2021 | 100 | 906,316 (3%) | 0% | 51.6 | 5,163 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 50.19 per share. | 22 Oct 2021 | 1,900 | 909,416 (3%) | 0% | 50.2 | 95,359 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 51.47 per share. | 15 Oct 2021 | 1,667 | 26,616 (0%) | 0% | 51.5 | 85,800 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 01 Oct 2021 | 340 | 33,009 (0%) | 0% | 51.2 | 17,408 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 51.18 per share. | 01 Oct 2021 | 254 | 96,012 (0%) | 0% | 51.2 | 13,000 | Common Stock |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 9,954 | 95,758 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 120,689 | 233,692 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 189,311 | 366,558 (1%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 9,952 | 85,804 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 120,689 | 354,381 (1%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 189,311 | 555,869 (1%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 51.18 per share. | 01 Oct 2021 | 232 | 11,892 (0%) | 0% | 51.2 | 11,874 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 51.18 per share. | 01 Oct 2021 | 354 | 15,348 (0%) | 0% | 51.2 | 18,118 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 51.18 per share. | 01 Oct 2021 | 269 | 13,930 (0%) | 0% | 51.2 | 13,767 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 01 Oct 2021 | 143 | 23,555 (0%) | 0% | 51.2 | 7,322 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 01 Oct 2021 | 342 | 36,848 (0%) | 0% | 51.2 | 17,511 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 49.22 per share. | 30 Sep 2021 | 4,600 | 914,910 (3%) | 0% | 49.2 | 226,433 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 47.54 per share. | 30 Sep 2021 | 400 | 919,510 (3%) | 0% | 47.5 | 19,016 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 30 Sep 2021 | 3,594 | 911,316 (3%) | 0% | 51.2 | 184,015 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 47.72 per share. | 22 Sep 2021 | 1,667 | 28,283 (0%) | 0% | 47.7 | 79,549 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 49.78 per share. | 01 Sep 2021 | 300 | 33,399 (0%) | 0% | 49.8 | 14,935 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 50.74 per share. | 01 Sep 2021 | 50 | 33,349 (0%) | 0% | 50.7 | 2,537 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 01 Sep 2021 | 534 | 924,910 (3%) | 0% | 50.7 | 27,100 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 50.25 per share. | 01 Sep 2021 | 4 | 919,910 (3%) | 0% | 50.3 | 201 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 49.66 per share. | 01 Sep 2021 | 4,996 | 919,914 (3%) | 0% | 49.7 | 248,106 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 49.78 per share. | 01 Sep 2021 | 3,175 | 925,444 (3%) | 0% | 49.8 | 158,058 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 50.76 per share. | 01 Sep 2021 | 21 | 23,698 (0%) | 0% | 50.8 | 1,066 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 49.79 per share. | 01 Sep 2021 | 126 | 23,719 (0%) | 0% | 49.8 | 6,273 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 01 Sep 2021 | 51 | 37,190 (0%) | 0% | 50.7 | 2,588 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 49.78 per share. | 01 Sep 2021 | 302 | 37,241 (0%) | 0% | 49.8 | 15,034 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 46.13 per share. | 20 Aug 2021 | 1,667 | 29,950 (0%) | 0% | 46.1 | 76,899 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 47.20 per share. | 16 Aug 2021 | 4,200 | 929,419 (3%) | 0% | 47.2 | 198,244 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 48.03 per share. | 16 Aug 2021 | 800 | 928,619 (3%) | 0% | 48.0 | 38,425 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 53.79 per share. | 03 Aug 2021 | 344 | 33,699 (0%) | 0% | 53.8 | 18,503 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 53.79 per share. | 03 Aug 2021 | 3,648 | 933,619 (3%) | 0% | 53.8 | 196,219 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 53.79 per share. | 03 Aug 2021 | 145 | 23,845 (0%) | 0% | 53.8 | 7,799 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 53.79 per share. | 03 Aug 2021 | 346 | 37,543 (0%) | 0% | 53.8 | 18,611 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 53.81 per share. | 29 Jul 2021 | 1,917 | 940,350 (3%) | 0% | 53.8 | 103,152 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 54.25 per share. | 29 Jul 2021 | 3,083 | 937,267 (3%) | 0% | 54.3 | 167,268 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 57.77 per share. | 14 Jul 2021 | 1,667 | 31,617 (0%) | 0% | 57.8 | 96,303 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.88 per share. | 13 Jul 2021 | 1,751 | 942,267 (3%) | 0% | 57.9 | 101,354 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 13 Jul 2021 | 3,249 | 944,018 (3%) | 0% | 57.2 | 185,911 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 59.35 per share. | 02 Jul 2021 | 127 | 34,043 (0%) | 0% | 59.3 | 7,537 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 57.64 per share. | 02 Jul 2021 | 167 | 34,222 (0%) | 0% | 57.6 | 9,626 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 58.38 per share. | 02 Jul 2021 | 52 | 34,170 (0%) | 0% | 58.4 | 3,036 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 59.34 per share. | 02 Jul 2021 | 1,342 | 947,267 (3%) | 0% | 59.3 | 79,639 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.64 per share. | 02 Jul 2021 | 1,767 | 949,158 (3%) | 0% | 57.6 | 101,849 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 58.39 per share. | 02 Jul 2021 | 549 | 948,609 (3%) | 0% | 58.4 | 32,055 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 57.64 per share. | 02 Jul 2021 | 70 | 24,066 (0%) | 0% | 57.6 | 4,035 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 58.41 per share. | 02 Jul 2021 | 22 | 24,044 (0%) | 0% | 58.4 | 1,285 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 59.35 per share. | 02 Jul 2021 | 54 | 23,990 (0%) | 0% | 59.4 | 3,205 | Common Stock |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 475,070 (1%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 745,180 (2%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,237 | 64,398 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 958,920 (3%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,237 | 53,161 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 747,590 (2%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 213,740 | 1,172,660 (4%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 136,260 | 611,330 (2%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 59.48 per share. | 01 Jul 2021 | 218 | 75,852 (0%) | 0% | 59.5 | 12,967 | Common Stock |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 11,236 | 75,634 (0%) | 0% | 0 | Common Stock | |
| Sarah E. Hlavinka | Director | Grant, award, or other acquisition of securities at price $ 59.48 per share. | 01 Jul 2021 | 199 | 11,660 (0%) | 0% | 59.5 | 11,837 | Common Stock |
| Martin D. Madaus | Director | Grant, award, or other acquisition of securities at price $ 59.48 per share. | 01 Jul 2021 | 304 | 14,994 (0%) | 0% | 59.5 | 18,082 | Common Stock |
| Paul M. Meister | Director | Grant, award, or other acquisition of securities at price $ 59.48 per share. | 01 Jul 2021 | 231 | 13,661 (0%) | 0% | 59.5 | 13,740 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 62.11 per share. | 23 Jun 2021 | 1,667 | 33,284 (0%) | 0% | 62.1 | 103,537 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 9,806 | 22,070 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 59.35 per share. | 21 Jun 2021 | 127 | 37,889 (0%) | 0% | 59.3 | 7,537 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 58.38 per share. | 21 Jun 2021 | 52 | 38,016 (0%) | 0% | 58.4 | 3,036 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 57.64 per share. | 21 Jun 2021 | 168 | 38,068 (0%) | 0% | 57.6 | 9,683 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 58.91 per share. | 21 Jun 2021 | 3,361 | 38,236 (0%) | 0% | 58.9 | 197,997 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 58.07 per share. | 21 Jun 2021 | 5,093 | 41,597 (0%) | 0% | 58.1 | 295,767 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.12 per share. | 21 Jun 2021 | 9,806 | 46,690 (0%) | 0% | 22.1 | 216,909 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 64.33 per share. | 21 Jun 2021 | 696 | 36,884 (0%) | 0% | 64.3 | 44,776 | Common Stock |
| Masoud Toloue | President, Quanterix & Dx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 50,703 | 50,703 (0%) | 0% | 0 | Common Stock | |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 4,906 | 21,275 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 8,124 | 31,876 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 3,336 | 21,304 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 2,030 | 23,970 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 07 Jun 2021 | 6,666 | 37,580 (0%) | 0% | 62 | 413,292 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 07 Jun 2021 | 6,883 | 44,246 (0%) | 0% | 57 | 392,331 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 07 Jun 2021 | 4,906 | 51,129 (0%) | 0% | 19.1 | 93,803 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.12 per share. | 07 Jun 2021 | 8,124 | 46,223 (0%) | 0% | 22.1 | 179,703 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.76 per share. | 07 Jun 2021 | 2,030 | 34,763 (0%) | 0% | 27.8 | 56,353 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 07 Jun 2021 | 3,336 | 38,099 (0%) | 0% | 22.7 | 75,721 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 48.32 per share. | 01 Jun 2021 | 226 | 34,389 (0%) | 0% | 48.3 | 10,920 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 49.47 per share. | 01 Jun 2021 | 2,500 | 955,925 (3%) | 0% | 49.5 | 123,678 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 48.96 per share. | 01 Jun 2021 | 2,500 | 958,425 (3%) | 0% | 49.0 | 122,407 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 48.32 per share. | 01 Jun 2021 | 3,854 | 960,925 (3%) | 0% | 48.3 | 186,218 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 48.32 per share. | 01 Jun 2021 | 153 | 24,136 (0%) | 0% | 48.3 | 7,393 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 48.32 per share. | 01 Jun 2021 | 243 | 32,733 (0%) | 0% | 48.3 | 11,741 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 28 May 2021 | 1,667 | 34,951 (0%) | 0% | 51 | 85,017 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 46.43 per share. | 13 May 2021 | 1,730 | 966,178 (3%) | 0% | 46.4 | 80,317 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 47.26 per share. | 13 May 2021 | 1,399 | 964,779 (3%) | 0% | 47.3 | 66,117 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 13 May 2021 | 1,871 | 967,908 (3%) | 0% | 45.5 | 85,057 | Common Stock |
| Shawn Stetson | Interim CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 3,321 | 3,321 | - | - | Stock Options (Right to buy) | |
| Shawn Stetson | Interim CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 1,423 | 4,712 (0%) | 0% | 0 | Common Stock | |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 May 2021 | 13 | 34,623 (0%) | 0% | 59 | 767 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 57.25 per share. | 03 May 2021 | 110 | 34,722 (0%) | 0% | 57.2 | 6,297 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 58.16 per share. | 03 May 2021 | 86 | 34,636 (0%) | 0% | 58.2 | 5,002 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 61.38 per share. | 03 May 2021 | 8 | 34,615 (0%) | 0% | 61.4 | 491 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.25 per share. | 03 May 2021 | 400 | 970,168 (3%) | 0% | 57.2 | 22,899 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 59.16 per share. | 03 May 2021 | 500 | 971,368 (3%) | 0% | 59.2 | 29,580 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 60.58 per share. | 03 May 2021 | 700 | 970,668 (3%) | 0% | 60.6 | 42,408 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 61.26 per share. | 03 May 2021 | 100 | 970,568 (3%) | 0% | 61.3 | 6,126 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 58.16 per share. | 03 May 2021 | 313 | 969,855 (3%) | 0% | 58.2 | 18,204 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 61.36 per share. | 03 May 2021 | 28 | 969,779 (3%) | 0% | 61.4 | 1,718 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 59.02 per share. | 03 May 2021 | 48 | 969,807 (3%) | 0% | 59.0 | 2,833 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.30 per share. | 03 May 2021 | 2,649 | 972,919 (3%) | 0% | 57.3 | 151,790 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 58.42 per share. | 03 May 2021 | 1,051 | 971,868 (3%) | 0% | 58.4 | 61,396 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 May 2021 | 9 | 24,294 (0%) | 0% | 59 | 531 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 61.40 per share. | 03 May 2021 | 5 | 24,289 (0%) | 0% | 61.4 | 307 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 58.16 per share. | 03 May 2021 | 58 | 24,303 (0%) | 0% | 58.2 | 3,373 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 57.25 per share. | 03 May 2021 | 75 | 24,361 (0%) | 0% | 57.3 | 4,294 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 May 2021 | 14 | 32,984 (0%) | 0% | 59 | 826 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 57.24 per share. | 03 May 2021 | 119 | 33,091 (0%) | 0% | 57.2 | 6,812 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 58.16 per share. | 03 May 2021 | 93 | 32,998 (0%) | 0% | 58.2 | 5,409 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 61.38 per share. | 03 May 2021 | 8 | 32,976 (0%) | 0% | 61.4 | 491 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.24 per share. | 03 May 2021 | 90 | 30,310 (0%) | 0% | 57.2 | 5,152 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.33 per share. | 03 May 2021 | 6 | 30,222 (0%) | 0% | 61.3 | 368 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 May 2021 | 11 | 30,228 (0%) | 0% | 59 | 649 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.15 per share. | 03 May 2021 | 71 | 30,239 (0%) | 0% | 58.2 | 4,129 | Common Stock |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 15,800 | 15,800 | - | - | Stock Option (right to buy) | |
| Laurie J. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 4,540 | 4,540 (0%) | 0% | 0 | Common Stock | |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 57.87 per share. | 20 Apr 2021 | 2,700 | 977,868 (3%) | 0% | 57.9 | 156,238 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 58.65 per share. | 20 Apr 2021 | 2,300 | 975,568 (3%) | 0% | 58.7 | 134,904 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 62.14 per share. | 15 Apr 2021 | 1,667 | 36,618 (0%) | 0% | 62.1 | 103,587 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 65.75 per share. | 08 Apr 2021 | 3,600 | 980,568 (3%) | 0% | 65.7 | 236,691 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 08 Apr 2021 | 1,400 | 984,168 (3%) | 0% | 65.0 | 91,012 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 62.70 per share. | 01 Apr 2021 | 126 | 34,847 (0%) | 0% | 62.7 | 7,900 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 61.92 per share. | 01 Apr 2021 | 60 | 34,973 (0%) | 0% | 61.9 | 3,715 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 63.33 per share. | 01 Apr 2021 | 15 | 34,832 (0%) | 0% | 63.3 | 950 | Common Stock |
| Keith L. Crandell | Director | Grant, award, or other acquisition of securities at price $ 61.45 per share. | 01 Apr 2021 | 211 | 41,924 (0%) | 0% | 61.5 | 12,966 | Common Stock |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 165,460 | 883,850 (3%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 13,644 | 41,713 (0%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 259,540 | 1,386,400 (4%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 165,460 | 1,049,310 (3%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 259,540 | 1,645,940 (5%) | 0% | 0 | Common Stock | |
| Keith L. Crandell | Director | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 13,643 | 28,069 (0%) | 0% | 0 | Common Stock | |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 63.36 per share. | 01 Apr 2021 | 260 | 985,568 (3%) | 0% | 63.4 | 16,474 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 62.70 per share. | 01 Apr 2021 | 2,148 | 985,828 (3%) | 0% | 62.7 | 134,676 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 61.92 per share. | 01 Apr 2021 | 1,024 | 987,976 (3%) | 0% | 61.9 | 63,406 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 63.40 per share. | 01 Apr 2021 | 10 | 24,436 (0%) | 0% | 63.4 | 634 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 62.69 per share. | 01 Apr 2021 | 85 | 24,446 (0%) | 0% | 62.7 | 5,329 | Common Stock |
| Mark T. Roskey | SVP, Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 61.93 per share. | 01 Apr 2021 | 41 | 24,531 (0%) | 0% | 61.9 | 2,539 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 62.70 per share. | 01 Apr 2021 | 135 | 33,226 (0%) | 0% | 62.7 | 8,464 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 01 Apr 2021 | 16 | 33,210 (0%) | 0% | 63.4 | 1,014 | Common Stock |
| Dawn Mattoon | Sr. VP, Diagnostics | Sale of securities on an exchange or to another person at price $ 61.92 per share. | 01 Apr 2021 | 64 | 33,361 (0%) | 0% | 61.9 | 3,963 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.70 per share. | 01 Apr 2021 | 103 | 30,413 (0%) | 0% | 62.7 | 6,458 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 01 Apr 2021 | 13 | 30,400 (0%) | 0% | 63.4 | 824 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.92 per share. | 01 Apr 2021 | 49 | 30,516 (0%) | 0% | 61.9 | 3,034 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 58.36 per share. | 19 Mar 2021 | 1,667 | 38,285 (0%) | 0% | 58.4 | 97,286 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 61.51 per share. | 16 Mar 2021 | 4,100 | 989,000 (3%) | 0% | 61.5 | 252,211 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 60.42 per share. | 16 Mar 2021 | 900 | 993,100 (3%) | 0% | 60.4 | 54,381 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 64.53 per share. | 08 Mar 2021 | 1,100 | 997,900 (3%) | 0% | 64.5 | 70,983 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 68.00 per share. | 08 Mar 2021 | 800 | 994,000 (3%) | 0% | 68 | 54,400 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 67.04 per share. | 08 Mar 2021 | 320 | 994,800 (3%) | 0% | 67.0 | 21,454 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 66.26 per share. | 08 Mar 2021 | 2,780 | 995,120 (3%) | 0% | 66.3 | 184,191 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 81.29 per share. | 01 Mar 2021 | 187 | 35,048 (0%) | 0% | 81.3 | 15,201 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 81.80 per share. | 01 Mar 2021 | 15 | 35,033 (0%) | 0% | 81.8 | 1,227 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.29 per share. | 01 Mar 2021 | 3,184 | 999,259 (3%) | 0% | 81.3 | 258,824 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 81.81 per share. | 01 Mar 2021 | 259 | 999,000 (3%) | 0% | 81.8 | 21,190 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 81.29 per share. | 01 Mar 2021 | 127 | 24,582 (0%) | 0% | 81.3 | 10,324 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 81.80 per share. | 01 Mar 2021 | 10 | 24,572 (0%) | 0% | 81.8 | 818 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 81.29 per share. | 01 Mar 2021 | 201 | 33,441 (0%) | 0% | 81.3 | 16,339 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 81.81 per share. | 01 Mar 2021 | 16 | 33,425 (0%) | 0% | 81.8 | 1,309 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.29 per share. | 01 Mar 2021 | 154 | 30,577 (0%) | 0% | 81.3 | 12,519 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.83 per share. | 01 Mar 2021 | 12 | 30,565 (0%) | 0% | 81.8 | 982 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 89.50 per share. | 19 Feb 2021 | 227 | 35,027 (0%) | 0% | 89.5 | 20,316 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 88.67 per share. | 19 Feb 2021 | 147 | 35,254 (0%) | 0% | 88.7 | 13,034 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 91.40 per share. | 19 Feb 2021 | 412 | 34,530 (0%) | 0% | 91.4 | 37,658 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 19 Feb 2021 | 85 | 34,942 (0%) | 0% | 90.2 | 7,671 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 91.40 per share. | 19 Feb 2021 | 317 | 24,435 (0%) | 0% | 91.4 | 28,974 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 90.26 per share. | 19 Feb 2021 | 66 | 24,752 (0%) | 0% | 90.3 | 5,957 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 89.50 per share. | 19 Feb 2021 | 174 | 24,818 (0%) | 0% | 89.5 | 15,573 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Sale of securities on an exchange or to another person at price $ 88.67 per share. | 19 Feb 2021 | 113 | 24,992 (0%) | 0% | 88.7 | 10,020 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 19 Feb 2021 | 85 | 34,054 (0%) | 0% | 90.2 | 7,671 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 91.40 per share. | 19 Feb 2021 | 412 | 33,642 (0%) | 0% | 91.4 | 37,658 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 88.67 per share. | 19 Feb 2021 | 147 | 34,366 (0%) | 0% | 88.7 | 13,034 | Common Stock |
| Dawn Mattoon | Sr. VP, Research Products | Sale of securities on an exchange or to another person at price $ 89.50 per share. | 19 Feb 2021 | 227 | 34,139 (0%) | 0% | 89.5 | 20,316 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 19 Feb 2021 | 72 | 30,769 (0%) | 0% | 90.3 | 6,498 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.67 per share. | 19 Feb 2021 | 124 | 31,032 (0%) | 0% | 88.7 | 10,995 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.40 per share. | 19 Feb 2021 | 346 | 30,423 (0%) | 0% | 91.4 | 31,625 | Common Stock |
| Amol Chaubal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.50 per share. | 19 Feb 2021 | 191 | 30,841 (0%) | 0% | 89.5 | 17,094 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 85.40 per share. | 18 Feb 2021 | 10 | 1,005,936 (3%) | 0% | 85.4 | 854 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 83.64 per share. | 18 Feb 2021 | 4,990 | 1,005,946 (3%) | 0% | 83.6 | 417,376 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 91.42 per share. | 18 Feb 2021 | 1,651 | 1,002,443 (3%) | 0% | 91.4 | 150,938 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 18 Feb 2021 | 342 | 1,004,094 (3%) | 0% | 90.3 | 30,866 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 89.50 per share. | 18 Feb 2021 | 909 | 1,004,436 (3%) | 0% | 89.5 | 81,355 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 88.67 per share. | 18 Feb 2021 | 591 | 1,005,345 (3%) | 0% | 88.7 | 52,403 | Common Stock |
| David C. Duffy | SVP R&D and CTO | Sale of securities on an exchange or to another person at price $ 79.62 per share. | 11 Feb 2021 | 1,667 | 39,952 (0%) | 0% | 79.6 | 132,727 | Common Stock |
| John J. Fry | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 8,585 | 8,585 | - | - | Stock Option (right to buy) | |
| John J. Fry | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 3,679 | 35,401 (0%) | 0% | 0 | Common Stock | |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 78.81 per share. | 08 Feb 2021 | 1,200 | 1,010,936 (3%) | 0% | 78.8 | 94,569 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 42,925 | 42,925 | - | - | Stock Option (right to buy) | |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 78.24 per share. | 08 Feb 2021 | 3,100 | 1,012,136 (3%) | 0% | 78.2 | 242,552 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 18,397 | 1,015,936 (3%) | 0% | 0 | Common Stock | |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 76.81 per share. | 08 Feb 2021 | 700 | 1,015,236 (3%) | 0% | 76.8 | 53,765 | Common Stock |
| Mark T. Roskey | SVP, Commercial & Accelerator | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 3,373 | 25,105 (0%) | 0% | 0 | Common Stock | |
| Mark T. Roskey | SVP, Commercial & Accelerator | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 7,870 | 7,870 | - | - | Stock Option (right to buy) | |
| David C. Duffy | SVP R&D and CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 2,146 | 41,619 (0%) | 0% | 0 | Common Stock | |
| David C. Duffy | SVP R&D and CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 5,008 | 5,008 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Research Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 8,585 | 8,585 | - | - | Stock Option (right to buy) | |
| Dawn Mattoon | Sr. VP, Research Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 3,679 | 34,513 (0%) | 0% | 0 | Common Stock | |
| Amol Chaubal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 13,507 | 13,507 | - | - | Stock Option (right to buy) | |
| Amol Chaubal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 5,789 | 31,156 (0%) | 0% | 0 | Common Stock | |
| William Geist | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 11,447 | 11,447 | - | - | Stock Option (right to buy) | |
| William Geist | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 4,906 | 44,951 (0%) | 0% | 0 | Common Stock | |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 67.93 per share. | 01 Feb 2021 | 68 | 31,817 (0%) | 0% | 67.9 | 4,619 | Common Stock |
| John J. Fry | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 68.49 per share. | 01 Feb 2021 | 95 | 31,722 (0%) | 0% | 68.5 | 6,507 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 68.49 per share. | 01 Feb 2021 | 1,890 | 1,002,539 (3%) | 0% | 68.5 | 129,451 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 67.93 per share. | 01 Feb 2021 | 1,359 | 1,004,429 (3%) | 0% | 67.9 | 92,317 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 66.51 per share. | 01 Feb 2021 | 600 | 997,539 (3%) | 0% | 66.5 | 39,908 | Common Stock |
| E. Kevin Hrusovsky | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 65.90 per share. | 01 Feb 2021 | 3,700 | 998,139 (3%) | 0% | 65.9 | 243,822 | Common Stock |